Ignite Creation Date:
2024-05-06 @ 3:29 PM
Last Modification Date:
2024-10-26 @ 1:50 PM
Study NCT ID:
NCT04653779
Status:
UNKNOWN
Last Update Posted:
2020-12-11
First Post:
2020-11-19
Brief Title:
A Clinical Trial to Evaluate the Preference Regarding Convenience of Medication and EfficacySafety of SUGAMETXR Tablet 51000mg
Sponsor:
Dong-A ST Co Ltd
Organization:
Dong-A ST Co Ltd
Study Overview
Official Title:
A Multi-center Open-label Single-arm Phase IV Clinical Trial to Evaluate the Preference Regarding Convenience of Medication Efficacy and Safety After Switching to SUGAMETXR Tablet 51000mg in Patients With Type 2 Diabetes and Renal Diseases
Status:
UNKNOWN
Status Verified Date:
2020-12
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Multi-center open-label single arm study to Evaluate the preference regarding convenience of medication efficacy and safety of Sugamet XR tab 51000mg in patients with Type 2 diabetes and renal diseases
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None